Gates Foundation Trust’s Oracle ORCL Stock Holding History

Gates Foundation Trust’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39,800	Closed	-$4.22M	–	57
2023 Q3	$4.22M	Buy	+39,800	New	+$4.61M	0.01%	32

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Gates Foundation Trust's ORCL Position: Q4 2023 in Review

Gates Foundation Trust sold out of Oracle (ORCL) in Q4 2023, closing a stake of 39,800 shares — an estimated $4.22M sold.

Gates Foundation Trust first reported a position in ORCL in Q3 2023 and held it in 1 quarter. The position peaked at $4.22M in Q3 2023. 2,695 funds tracked by Wall St. Rank hold ORCL as of Q4 2023.

Gates Foundation Trust reported no remaining Oracle position as of Q4 2023 after selling out during the quarter.
Gates Foundation Trust sold 39,800 Oracle shares in Q4 2023, an estimated $4.22M.
Gates Foundation Trust first reported a position in Oracle in Q3 2023 and held it in 1 quarter.
Gates Foundation Trust's Oracle position peaked at $4.22M in Q3 2023.
2,695 funds tracked by Wall St. Rank held Oracle as of Q4 2023.

Based on Gates Foundation Trust's 13F filing for Q4 2023, filed 14 Feb 2024.